Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OPKO Health Inc (NASDAQ:OPK)

7.77
Delayed Data
As of Apr 28
 -0.06 / -0.77%
Today’s Change
7.11
Today|||52-Week Range
12.15
-16.45%
Year-to-Date
Weekly CEO Buys Highlights
Apr 24 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close7.83
Today’s open7.81
Day’s range7.75 - 7.85
Volume1,682,157
Average volume (3 months)4,720,012
Market cap$4.4B
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+16.67%
Earnings growth (this year)-136.00%
Earnings growth (next 5 years)+40.10%
Revenue growth (last year)+148.44%
P/E ratioNM
Price/Sales4.19
Price/Book2.09

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc+3.01+0.35%
ALNYAlnylam Pharmaceutic...+0.83+1.57%
AKRXAkorn Inc+0.11+0.33%
ACADACADIA Pharmaceutica...+0.50+1.48%
Data as of 4:14pm ET, 04/28/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$1.2B
Annual profit (last year)-$25.1M
Net profit margin-2.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
CFO, Treasurer, &
Chief Accounting Officer
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts